Daxor Corporation (DXR) vs Nyxoah SA (NYXH)
- Daxor Corporation DXR 10.05 −1.47%
- Nyxoah SA NYXH 1.11 −6.72%
Daxor Corporation and Nyxoah SA are both Medical Instruments & Supplies companies. Nyxoah SA is the larger, with a market value of $121.2M against $59.6M — 2.0× the size. Nyxoah SA has negative trailing earnings, so its P/E is not meaningful; Daxor Corporation trades at 4.7×. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against −52.1%. Daxor Corporation has the higher net margin (−251.9% vs −446.4%) and the higher return on invested capital (0.00% vs −117.8%). Across the 17 metrics below, Daxor Corporation leads on 12 and Nyxoah SA on 5.
Valuation
Profitability
| Metric | DXR | NYXH | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 0.00% | 60.16% | 54.29% |
| Operating margin | 0.00% | (391.25%) | 1.07% |
| Net margin | (251.91%) | (446.39%) | (1.61%) |
| Free cash flow margin | 224.51% | (344.99%) | 1.08% |
| Return on equity | 37.62% | (124.41%) | (1.32%) |
| Return on assets | 35.90% | (68.23%) | 0.00% |
| Return on invested capital | 0.00% | (117.82%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack